期刊文献+

多巴胺β羟化酶基因多态性与帕金森病遗传易感性 被引量:10

Dopamine beta hydroxylase gene polymorphism and Parkinson's disease
原文传递
导出
摘要 目的 探讨多巴胺β羟化酶 ( dopamine beta hydroxylase,DBH)基因内含子 5 Taq 多态性与帕金森病遗传易感性的关系。方法 用聚合酶链反应 -限制性长度片段多态性技术检测了 14 4例原发性帕金森病患者和年龄及性别相匹配的 188名健康人多巴胺β羟化酶基因内含子 5 Taq 多态性。结果 与健康人比较 ,帕金森病患者 DBH基因内含子 5 Taq 基因型 ( A1/ A2 ,A2 / A2 )或等位基因 ( A1,A2 )的分布不同 ,两组之间的差异有显著性 (基因型 :A1/ A2  OR=0 .4 5 ,Z=10 .11,P<0 .0 1;A2 / A2  OR=2 .11,Z=10 .6 6 ,P<0 .0 1;等位基因 :A1  OR=0 .5 4 ,Z=10 .2 0 ,P<0 .0 1;A2  OR=1.82 ,Z=10 .89,P<0 .0 1)。结论  DBH基因 Taq Objective: To investigate the correlation between the polymorphism of dopamine beta hydroxylase (DBH) gene and the susceptibility of Shanghai Chinese Han population to Parkinson's disease (PD). Methods: Association study was performed in 144 PD patients and 188 healthy control subjects matched for age, sex and origin. Polymorphism of DBH gene was analyzed with polymerase chain reaction-restricton fragement length polymorphism. Results: The allelic frequency of A2 allele of DBH gene was significantly higher in PD patients than in controls (P<0.01). The risk of suffering from PD increased (OR =1.82) in the individual with A2 allele. And the genotypic frequency of A2/A2 was significantly higher in PD patients (OR=2.11, P<0.01), too. On the other hand, the allelic frequency of A1 allele and the genotypic frequency of A1/A2 genotype of DBH gene in PD patients were significantly lower (A1 alleles: OR=0.54, P<0.01; A1/A2 genotypes: OR=0.45,P<0.01). Conclusion: The polymorphism in DBH gene might play an important role in the susceptibility of Shanghai Chinese Han population to PD.
出处 《中华医学遗传学杂志》 EI CAS CSCD 2003年第3期238-240,共3页 Chinese Journal of Medical Genetics
  • 相关文献

参考文献11

  • 1Zabetian CP, Anderson GM, Buxbaum SG, et al. A quantitativetrait analysis of human plasma-dopamine beta-hydroxylase activity : evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet, 2001, 68: 515-522.
  • 2Roman T, Schmitz M, Polanczyk GV, et al. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet,2002, 114: 154-158.
  • 3Gaspar P, Duyckaerts C, Alvarez C, et al. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol, 1991, 30: 365-374.
  • 4Cubells JF, van Kammen DP, Kelley ME, et al. Dopamine betahydroxylase:two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet, 1998, 102 : 533-540.
  • 5Wei J, Ramchand CN, Hemmings GP. Taq Ⅰ polymorphic sites at the human dopamine beta-hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophrenia. Psychiatr Genet, 1998, 8: 19-24.
  • 6Mayeux R. The mental state in Parkinson's disease. In:Koller WC ed. Handbook of Parkinson's disease. 2nd ed. New York:Marcel Dekker Inc. 1992. 1593.
  • 7Murray JB. Depression in Parkinson's disease. J Psychol, 1996,130 : 659-667.
  • 8Wermuth L, Knudsen L, Boldsen J. A study of cognitive functions in young Parkinson's patients. Acta Neurol Scand,1996,93: 21-24.
  • 9Friedman A, Barcikowska M. Dementia in Parkinson's disease.Dementia, 1994,5: 12-16.
  • 10Fahim S, van Duijn CM, Baker FM, et al. A study of familial aggregation of depression, dementia and Parkinson's disease. Eur J Epidemiol, 1998,14: 233-238.

同被引文献115

引证文献10

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部